Eric Alvarez-Freire

Alicante, VC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Quality of "on": a novel therapeutic objective in advanced Parkinson's disease.

Quality of "on": a novel therapeutic objective in advanced Parkinson's disease.

Journal: Parkinsonism & related disorders

Published: February 12, 2026

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease.

Considerations for Initiation and Maintenance of Foslevodopa/Foscarbidopa for Advanced Parkinson's Disease.

Journal: Movement disorders clinical practice

Published: August 05, 2025

Spanish expert consensus statement on the use of inhaled levodopa for the treatment of fluctuations in Parkinson's disease.

Spanish expert consensus statement on the use of inhaled levodopa for the treatment of fluctuations in Parkinson's disease.

Journal: Neurologia

Published: April 09, 2025

Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson's disease.

Post hoc exploratory analysis of the effect of foslevodopa/foscarbidopa continuous subcutaneous infusion on nocturia in patients with Parkinson's disease.

Journal: Clinical parkinsonism & related disorders

Published: January 24, 2025

Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study.

Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study.

Journal: Computers in biology and medicine

Published: May 22, 2024

Concerns with the new biological research criteria for synucleinopathy.

Concerns with the new biological research criteria for synucleinopathy.

Journal: The Lancet. Neurology

Published: February 20, 2024

Dyskinesia and Pain in Advanced Parkinson's Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study.

Dyskinesia and Pain in Advanced Parkinson's Disease: Post Hoc Analysis from the Phase 3b, Open-Label, Randomized DYSCOVER Study.

Journal: Neurology and therapy

Published: November 27, 2023

Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.

Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance.

Journal: Clinical parkinsonism & related disorders

Published: November 17, 2023

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.

Correction: Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.

Journal: Neurology and therapy

Published: October 10, 2023

SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.

SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.

Journal: Revista de neurologia

Published: September 27, 2023

Combined subthalamic nucleus and globus pallidus internus deep brain stimulation in Parkinson's disease.

Combined subthalamic nucleus and globus pallidus internus deep brain stimulation in Parkinson's disease.

Journal: Revista de neurologia

Published: July 19, 2023

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.

Continuous Subcutaneous Foslevodopa/Foscarbidopa in Parkinson's Disease: Safety and Efficacy Results From a 12-Month, Single-Arm, Open-Label, Phase 3 Study.

Journal: Neurology and therapy

Published: June 09, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026